|
|||||
|
|
Signal detection on a patient cohort: A disproportionality analysis of the ANRS CO22 HEPATHER cohort to identify associations between direct acting antivirals and adverse events in patients with hepatitis C virus chronic infection |
|
| Authors: | Sarah F. Feldman Nathanaël Lapidus Céline Dorival Alpha Diallo Imane Amri Hélène Fontaine Stanislas Pol Fabrice Carrat for the ANRS/AFEF HEPATHER study group |
| Affiliation: | 1. Assistance Publique‐H?pitaux de Paris, H?pital Saint Antoine, Unité de Santé Publique, Paris, France;2. Sorbonne Université, INSERM, Institut Pierre Louis d'épidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France;3. ANRS (France REcherche Nord&sud Sida‐hiv Hépatites), Clinical trial safety and Public Health, Paris, France;4. Université Paris Descartes;5. APHP, Unité d'Hépatologie, H?pital Cochin;6. INSERM U‐818 et USM20, Institut Pasteur, Paris, France |
| Abstract: | |
| Keywords: | adverse drug event cohort studies hepatitis C pharmacoepidemiology Pharmacovigilance |